Study on the risk signal mining related to romiplostim based on the US Food and Drug Administration Adverse Event Reporting System

Zhou Zhangjiuzhi, Ma Leping, Zhang Wei, Li Zhaoxue

PDF(429 KB)
PDF(429 KB)
Adverse Drug Reactions Journal ›› 2023, Vol. 25 ›› Issue (3) : 165-171. DOI: 10.3760/cma.j.cn114015-20221008-00893

Study on the risk signal mining related to romiplostim based on the US Food and Drug Administration Adverse Event Reporting System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 25(3): 165-171 https://doi.org/10.3760/cma.j.cn114015-20221008-00893

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(429 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉